Whole-genome microarray analysis of patient samples revealed that overexpression of cyclin-dependent kinase 5 (CDK5), an important prognostic marker for the development of malignant colorectal cancer (CRC), could directly activate ERK5 and promote progression of colorectal cancer via activator protein-1 (AP-1) [24]. This evidence concerns the gene FOS and colorectal cancer.